AAAAAA
Results: 1-25/26
Authors:
PINTO A
ZULIAN GB
ARCHIMBAUD E
Citation: A. Pinto et al., ACUTE MYELOGENOUS LEUKEMIA, Critical reviews in oncology/hematology, 27(2), 1998, pp. 161-164
Authors:
ZULIAN GB
BABARE R
ZAGONEL V
Citation: Gb. Zulian et al., MULTIPLE-MYELOMA, Critical reviews in oncology/hematology, 27(2), 1998, pp. 165-167
Authors:
LUDWIG H
FRITZ E
ZULIAN GB
BROWMAN GP
Citation: H. Ludwig et al., SHOULD ALPHA-INTERFERON BE INCLUDED AS STANDARD TREATMENT IN MULTIPLE-MYELOMA, European journal of cancer, 34(1), 1998, pp. 12-17
Authors:
ZULIAN GB
Citation: Gb. Zulian, SHOULD ALPHA-INTERFERON BE INCLUDED AS STANDARD TREATMENT IN MULTIPLE-MYELOMA - CONTRA, European journal of cancer, 34(1), 1998, pp. 18-22
Authors:
ZULIAN GB
Citation: Gb. Zulian, HEALTH-CARE-DELIVERY IN THE OLDER PERSON - FOLLOW-UP AND GENERAL-PRACTITIONERS, Annals of oncology, 9, 1998, pp. 57-57
Authors:
MERMINOD T
MICHEL JP
ZULIAN GB
Citation: T. Merminod et al., MULTIPLE MALIGNANT-TUMORS IN THE ELDERLY, Annals of oncology, 9, 1998, pp. 123-123
Authors:
ZULIAN GB
Citation: Gb. Zulian, THE MEDICAL ONCOLOGIST IN A DEPARTMENT OF GERIATRIC-MEDICINE, Annals of oncology, 9, 1998, pp. 150-150
Authors:
GREMAUD G
ZULIAN GB
Citation: G. Gremaud et Gb. Zulian, INDICATIONS AND LIMITATIONS OF INTRAVENOUS AND SUBCUTANEOUS MIDAZOLAMIN A PALLIATIVE CARE CENTER, Journal of pain and symptom management, 15(6), 1998, pp. 331-333
Authors:
BETTICHER DC
VONROHR A
RATSCHILLER D
SCHMITZ SFH
EGGER T
SONDEREGGER T
HERRMANN R
KRONER T
ZULIAN GB
CAVALLI F
FEY MF
CERNY T
Citation: Dc. Betticher et al., FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(3), 1998, pp. 850-858
Authors:
LAURENCET FM
ZULIAN GB
DIETRICH PY
Citation: Fm. Laurencet et al., PNEUMOTHORAX FOLLOWING INDUCTION CHEMOTHERAPY FOR A GERM-CELL TUMOR, European journal of cancer, 33(1), 1997, pp. 169-170
Authors:
LAURENCET FM
ZULIAN GB
BAUER J
MERMILLOD B
ITEN PA
ALBERTO P
Citation: Fm. Laurencet et al., FEASIBILITY, TOXICITY, AND ACTIVITY OF LNH84-DERIVED CHEMOTHERAPY IN THE MANAGEMENT OF AGGRESSIVE LYMPHOMAS, American journal of hematology, 55(4), 1997, pp. 199-204
Authors:
LAURENCET FM
ZULIAN GB
CABROL C
BETTICHER DC
Citation: Fm. Laurencet et al., MYELODYSPLASTIC SYNDROME WITH BICLONAL MONOSOMY-7 AND TRISOMY-8 AFTERTREATMENT WITH CLADRIBINE (2-CHLORO-2-DEOXYADENOSINE) AND INVOLVED FIELD RADIATION-THERAPY, Cancer genetics and cytogenetics, 99(1), 1997, pp. 85-89
Authors:
ZULIAN GB
Citation: Gb. Zulian, MULTIPLE-MYELOMA - CLINICAL-EVALUATION OF PLASMA-CELL LYMPHOPROLIFERATIVE DISORDERS AND INITIAL MANAGEMENT, Seminars in hematology, 34(1), 1997, pp. 29-39
Authors:
LAURENCET FM
ZULIAN GB
DIETRICH PY
ANCHISI S
MERMILLOD B
ALBERTO P
Citation: Fm. Laurencet et al., TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMP HOMA - THE EXPERIENCE OF A GENERAL-HOSPITAL, Bulletin du cancer, 83(10), 1996, pp. 864-869
Authors:
PECHERE M
ZULIAN GB
VOGEL JJ
JEANPRETRE M
HIRSCHEL B
SAURAT JH
Citation: M. Pechere et al., FINGERTIP NECROSIS DURING CHEMOTHERAPY WITH BLEOMYCIN, VINCRISTINE AND METHOTREXATE FOR HIV-RELATED KAPOSIS-SARCOMA, British journal of dermatology, 134(2), 1996, pp. 378-379
Authors:
ZULIAN GB
MERMILLOD B
ITEN PA
ALBERTO P
Citation: Gb. Zulian et al., VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP) AS FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD), European journal of cancer, 31A, 1995, pp. 805-805
Authors:
ANCHISI S
ZULIAN GB
DIETRICH PY
ALBERTO P
Citation: S. Anchisi et al., CLADRIBINE AND TUMOR LYSIS SYNDROME, European journal of cancer, 31A(1), 1995, pp. 131-132
Authors:
ZULIAN GB
DIETRICH PY
CONNE B
ANCHISI S
PACHE JC
ROUDEN C
ALBERTO P
Citation: Gb. Zulian et al., LYMPHOMA OF UNCERTAIN PHENOTYPE, Annals of oncology, 6(8), 1995, pp. 827-832
Authors:
ZULIAN GB
TULLEN E
MATON B
Citation: Gb. Zulian et al., METHYLENE-BLUE FOR IFOSFAMIDE-ASSOCIATED ENCEPHALOPATHY, The New England journal of medicine, 332(18), 1995, pp. 1239-1240
Authors:
ZULIAN GB
ROUX E
TIERCY JM
EXTERMANN M
DIEBOLDBERGER S
REYMOND JM
HELG C
ZUBLER R
BETTICHER DC
ALBERTO P
JEANNET M
CHAPUIS B
Citation: Gb. Zulian et al., TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN A PATIENT TREATEDWITH CLADRIBINE (2-CHLORODEOXYADENOSINE) - DEMONSTRATION OF EXOGENOUSDNA IN VARIOUS TISSUE-EXTRACTS BY PCR ANALYSIS, British Journal of Haematology, 89(1), 1995, pp. 83-89
Authors:
ZULIAN GB
MERMILLOD B
ITEN PA
ALBERTO P
Citation: Gb. Zulian et al., FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD) WITH VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP), Blood, 86(10), 1995, pp. 3295-3295
Authors:
DEPREE C
GIOSTRA E
GALETTO A
PERRIN L
ZULIAN GB
Citation: C. Depree et al., HEPATITIS-C VIRUS ACUTE EXACERBATION DURING CHEMOTHERAPY AND RADIOTHERAPY FOR ESOPHAGEAL-CARCINOMA, Annals of oncology, 5(9), 1994, pp. 861-862
Authors:
BONNEFOI H
ZULIAN GB
MIRIMANOFF RO
MERMILLOD B
ALBERTO P
Citation: H. Bonnefoi et al., PRIMING LOW-DOSE CHEST RADIOTHERAPY FOLLOWED BY CHEMOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER, Annals of oncology, 5(8), 1994, pp. 771-772
Authors:
ZULIAN GB
AAPRO MS
Citation: Gb. Zulian et Ms. Aapro, DOCETAXEL AND RADIATION-RECALL SEVERE MUCOSITIS, Annals of oncology, 5(10), 1994, pp. 964-964
Authors:
VOUILLOZ C
GRAF JH
ZULIAN GB
Citation: C. Vouilloz et al., POLYCYTHEMIA-VERA COMPLICATED BY SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS, American journal of hematology, 47(2), 1994, pp. 148-149